These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 21669251)
1. Vitamin D metabolism in mammary gland and breast cancer. Welsh J Mol Cell Endocrinol; 2011 Dec; 347(1-2):55-60. PubMed ID: 21669251 [TBL] [Abstract][Full Text] [Related]
2. Function of the vitamin D endocrine system in mammary gland and breast cancer. Welsh J Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119 [TBL] [Abstract][Full Text] [Related]
3. Targets of vitamin D receptor signaling in the mammary gland. Welsh J J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Atkins GJ; Anderson PH; Findlay DM; Welldon KJ; Vincent C; Zannettino AC; O'Loughlin PD; Morris HA Bone; 2007 Jun; 40(6):1517-28. PubMed ID: 17395559 [TBL] [Abstract][Full Text] [Related]
5. Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling. Ormsby RT; Findlay DM; Kogawa M; Anderson PH; Morris HA; Atkins GJ J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():110-3. PubMed ID: 24120913 [TBL] [Abstract][Full Text] [Related]
6. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461 [TBL] [Abstract][Full Text] [Related]
7. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells. Valrance ME; Brunet AH; Acosta A; Welsh J J Cell Biochem; 2007 Aug; 101(6):1505-19. PubMed ID: 17286279 [TBL] [Abstract][Full Text] [Related]
8. Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway. Kemmis CM; Welsh J J Cell Biochem; 2008 Nov; 105(4):980-8. PubMed ID: 18767073 [TBL] [Abstract][Full Text] [Related]
9. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D. Anderson PH; O'Loughlin PD; May BK; Morris HA J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):111-3. PubMed ID: 15225756 [TBL] [Abstract][Full Text] [Related]
10. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D and the mammary gland: a review on its role in normal development and breast cancer. Lopes N; Paredes J; Costa JL; Ylstra B; Schmitt F Breast Cancer Res; 2012 May; 14(3):211. PubMed ID: 22676419 [TBL] [Abstract][Full Text] [Related]
12. RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)2D3 synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. Anderson PH; Atkins GJ; Findlay DM; Oloughlin PD; Welldon K; Vincent C; Morris HA J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):601-5. PubMed ID: 17254772 [TBL] [Abstract][Full Text] [Related]
13. CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Jacobs ET; Van Pelt C; Forster RE; Zaidi W; Hibler EA; Galligan MA; Haussler MR; Jurutka PW Cancer Res; 2013 Apr; 73(8):2563-73. PubMed ID: 23423976 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D Yang D; Anderson PH; Turner AG; Morris HA; Atkins GJ J Steroid Biochem Mol Biol; 2016 Nov; 164():374-378. PubMed ID: 26949105 [TBL] [Abstract][Full Text] [Related]
16. A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues. Suetani RJ; Ho K; Jindal S; Manavis J; Neilsen PM; Pishas KI; Rippy E; Bochner M; Kollias J; Gill PG; Morris HA; Callen DF Mol Cell Endocrinol; 2012 Oct; 362(1-2):202-10. PubMed ID: 22750718 [TBL] [Abstract][Full Text] [Related]
17. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol. Diesel B; Radermacher J; Bureik M; Bernhardt R; Seifert M; Reichrath J; Fischer U; Meese E Clin Cancer Res; 2005 Aug; 11(15):5370-80. PubMed ID: 16061850 [TBL] [Abstract][Full Text] [Related]
19. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation. Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583 [TBL] [Abstract][Full Text] [Related]
20. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Anderson PH; O'Loughlin PD; May BK; Morris HA Bone; 2005 Apr; 36(4):654-62. PubMed ID: 15781002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]